The first clinical trials for a new Covid-19 vaccine will go ahead on humans at Oxford University from Thursday and in Langen, Germany.
Britain’s Secretary of State for Health Matt Hancock confirmed this in briefing that clinical trials for a new Covid-19 vaccine will go ahead on humans in Oxford from today, Thursday.
Pfizer Inc. and BioNTech SE secured approval for Germany’s first human clinical trials of a possible coronavirus vaccine, entering a global race to develop a defense against the pandemic.
Regulators gave the green light to test the companies’ proposed vaccine on 200 healthy people aged 18 to 55 years in a first stage, and on additional high-risk candidates in a second stage, according to a statement Wednesday. Shares of Mainz-based BioNTech rose as much as 63% in Frankfurt.
